Brenna Koval
Patent Data Editor
Drug patent portfolios, expiration timelines, and patent-cliff data
Brenna Koval leads how PatentCliff reads and presents U.S. patent data. The role decides which USPTO PatentsView fields each drug, company, and report page uses, computes expected expirations from grant date plus term-adjustment days, cross-references the FDA Orange Book for generic-launch timing, and triages corrections. Patent and expiration figures are drafted with AI assistance and editorially reviewed against the underlying USPTO PatentsView and Orange Book releases before publication.
Areas of focus
How our content is produced
Content is produced by an AI-augmented editorial team: research and drafting are AI-assisted and reviewed by the named desk editor against primary public-data sources before publication.
See our Editorial Policy, Fact-Checking Policy, and Corrections Policy.